This is a preview of subscription content, log in via an institution to check access.
References
National Institute for Clinical Excellence. NICE draft guidance recommends wider use of abatacept in treating rheumatoid arthritis. Media Release : 5 Dec 2012. Available from: URL: http://www.nice.org.uk
NICE. NICE says yes to ranibizumab for diabetic macular oedema in final draft guidance after rapid review. Media Release : 3 Jan 2013. Available from: URL: http://www.nice.org.uk
NICE. NICE says yes in draft guidance to eltrombopag for the treatment of chronic immune (idiopathic) thrombocytopenic purpura. Media Release : 19 Dec 2012. Available from: URL: http://www.nice.org.uk
NICE. NICE consults on preliminary recommendations for a new kidney cancer drug. Media Release : 6 Dec 2012. Available from: URL: http://www.nice.org.uk
NICE. NICE draft guidance does not recommend bevacizumab as advanced ovarian cancer treatment. Media Release : 17 Dec 2012. Available from: URL: http://www.nice.org.uk
NICE. NICE publishes evidence summary on the unlicensed and off-label use of melatonin to treat sleep disorders in children and young people with ADHD. Media Release : 3 Jan 2013. Available from: URL: http://www.nice.org.uk
Rights and permissions
About this article
Cite this article
Recent decisions from NICE. PharmacoEconomics & Outcomes News 669, 9 (2013). https://doi.org/10.1007/s40274-013-0062-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0062-x